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Abstract
Background: The number of hip fractures and resulting post-surgical outcome are a major public health concern
and the incidence is expected to increase significantly. The acute recovery phase after hip fracture surgery in elder
patients is often complicated by severe pain, high morphine consumption, perioperative blood loss with subsequent
transfusion and delirium. Postoperative continuous-flow cryocompression therapy is suggested to minimize these
complications and to attenuate the inflammatory reaction that the traumatic fracture and subsequent surgical trauma
encompass. Based on a pilot study in patients undergoing total hip arthroplasty for osteoarthritis, it is anticipated that
patients treated with continuous-flow cryocompression therapy will have less pain, less morphine consumption and
lower decrease of postoperative hemoglobin levels. These factors are associated with a shorter hospital stay and better
long-term (functional) outcome.
Methods/design: One hundred and sixty patients with an intra or extracapsular hip fracture scheduled for internal
fixation (intramedullary hip nail, dynamic hip screw or cannulated screws) or prosthesis surgery (total hip or
hemiarthroplasty) will be included in this prospective, open-label, parallel, multicenter, randomized controlled,
clinical superiority trial. Patients will be allocated to two treatment arms: group ‘A’ will be treated with
continuous-flow cryocompression therapy and compared to group ‘B’ that will receive standard care. Routine
use of drains and/or compressive bandages is allowed in both groups. The primary objective of this study is
to compare acute pain the first 72 h postoperative, measured with numeric rating scale for pain. Secondary
objectives are: (non-) morphine analgesic use; adjusted postoperative hemoglobin level; transfusion incidence;
incidence, duration and severity of delirium and use of psychotropic medication; length of stay; location and
duration of rehabilitation; functional outcome; short-term patient-reported health outcome; general and
cryotherapy related complications and feasibility.
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Discussion: This is the first randomized controlled trial that will assess the analgesic efficiacy of continuous-
flow cryocompression therapy in the acute recovery phase after hip fracture surgery.
Trial registration: www.trialregister.nl, NTR4152 (23rd of August 2013)
Keywords: Hip fracture, Cryotherapy, Induced hypothermia, Intermittent pneumatic compression device, Pain,
Analgesia, Opioid analgesics, Morphine, Hemoglobin, Delirium, Length of stay, Functional outcome, Patient-reported
outcome, Complications
Background
Hip fractures are one of the most important causes of long-
term disability and a significant public health issue [1]. Inci-
dence varies on a global scale [2, 3] but incidence is esti-
mated to vary between 414 and 957 per 100,000 inhabitants
in the USA [4]. Due to aging of the population in general a
significant increase in hip fracture numbers is expected [5].
Hip fractures are a serious condition associated with
high morbidity, one-year mortality rates up to 29 % [2,
4], severe pain [6, 7] and significant decline in functional
status [8–11]. Less than 50 % of (semi-) independent liv-
ing elders return to their pre-fracture habitat [11, 12].
Among the most serious of complications is the onset of
delirium, which has a particular high incidence of 45 %
in hip fracture populations [13–15]. Possibly because
this condition is known to be extremely painful [15–18]
and patients with pain are nine times more likely to de-
velop a delirium [18–20] and furthermore take longer to
ambulate and consequently, have longer length of stay [9].
Upon admission 40 % of hip fracture patients is anemic
[21] and observed intraoperative blood loss is systematic-
ally underestimated; up to six-fold in excess in extracapsu-
lar fractures [22]. The continued postoperative decline in
hemoglobin levels results from, among others, surgical site
bleeding [22]. This yields a specifically high transfusion
rate in this frail elderly patient category where use antico-
agulants or thrombocyte aggregation inhibitors is rela-
tively prevalent [23]. Besides (postoperative) surgical site
bleeding, the fracture trauma and subsequent surgical
stabilization procedure induce a inflammatory response
causing leakage of plasma proteins and migration of
inflammatory cells that lead to local peripheral vasodilata-
tion and increased capillary permeability, ultimately caus-
ing edema [24]. Edema gradually develops during the first
week post surgery, is more pronounced in intertrochan-
teric fractures and correlates well with reduced knee ex-
tension strength and functional performance [25, 26]. In
an attempt to reduce edema and postoperative hemorrha-
ging compressive wound dressings are applied [27–29].
Dynamic pneumatic compressive devices not only reduce
blood loss, edema and offer a better (hemo) dynamic pro-
file in the deep venous and lymph system, it also exerts
analgesic effects and reduces the inflammatory response
when combined with a cryotherapy adjunct [30–35].
In a pilot study on 30 patients in a Dutch teaching
hospital an apparatus with continuous-flow cryotherapy
combined with intermittent compression was used in
the postoperative setting of hip arthroplasty for end-
stage osteoarthritis [36]. A trend towards lower visual
analogue scale (VAS) pain scores and less morphine
use was observed, and patients receiving continuous-
flow cryocompression (CFC) therapy had statistical
significant less decline in postoperative hemoglobin
levels. In two randomized controlled trials evaluating
continuous-flow cryotherapy (without a compression
adjunct) in 45 total hip [37] and 208 total hip and
knee arthroplasty [38] patients, lower pain scores were
observed and less morphine was used. Furthermore
length of stay was 1.4 days shorter when continuous-
flow cryotherapy was applied after hip arthroplasty in
74 patients [39].
Currently all published trials studying CFC therapy
focus on semi-elective procedures such as anterior
cruciate ligament reconstruction and total knee arthro-
plasties [40]. To our knowledge, no randomized con-
trolled trial exists evaluating the efficacy of CFC therapy
in the acute postoperative recovery phase of hip fracture
patients [40]. As hip fracture patients have duplicate
trauma, severe pain, fracture site bleeding with related
inflammation and associated soft tissue damage they are
expected to benefit most from CFC therapy.
Aim
The aim of the current study is to evaluate the efficacy of
CFC therapy on pain in the first 72 postoperative hours of
hip fracture patients. The secondary aim is to evaluate the
effects on (non-) morphine analgesic use; postoperative
hemoglobin level; transfusion incidence; delirium incidence
and severity; use of psychotropic medication; length of
stay; short-term location and duration of rehabilitation;
functional outcome; short-term patient-reported health
outcome; general and cryotherapy related complica-
tions. Furthermore the feasibility of a cryocompression
device on orthopedic/surgery wards is assessed.
We hypothesized that: 1) CFC therapy will lower
perceived pain levels and morphine consumption; and
2) will reduce postoperative blood loss and transfusion
incidence; and 3) reduced pain by CFC therapy will
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lead to lower delirium incidence and 4) enhance func-
tional recovery, leading to shorter length of stay in
postoperative hip facture patients.
Methods
Study design
This study is designed as a prospective, open-label, parallel,
multicenter, 1:1 randomized controlled, clinical superiority
trial in accordance with CONSORT and SPIRIT guidelines
[41, 42]. Eight orthopedic, surgery and/or geriatric depart-
ments of three middle sized teaching hospitals and one
academic hospital in the Netherlands will participate: The
Spaarne Gasthuis, Hoofddorp and Haarlem; Noordwest
Ziekenhuisgroep, Alkmaar; Amstelland Hospital, Amstelv-
een; VU University Medical Center, Amsterdam.
Randomization
A balanced 1:1 block (size six) randomization stratified
by center will be performed directly after surgery, using
Research Manager (RM; version 4.5.0.1), a web-based
computer program (Fig. 1). A research nurse who is not
involved in the study generates the allocation sequence
with RM. Intramedullary hip nail (IMHN), dynamic hip
screw (DHS) and cannulated screws are grouped for block
randomization, as are total hip arthroplasty (THA) and
hemiarthroplasty (HA). The intervention group ‘A’ will re-
ceive CFC therapy postoperative; the control group ‘B’ will
receive standard care. Due to the nature of the study no
blinding can exist as patients, family and physicians notice
the use and settings of CFC therapy. Physicians randomize
participants with a digital logon to the web-based system
or the physician can contact the coordinating investigator
and he will randomize the included participant (see Table
1 for criteria).The Informant Questionnaire for the Cogni-
tive Decline in the Elderly (IQ-CODE) questionnaire is ad-
ministered when the clinician has doubts about the
cognitive state that may compromise CFC therapy ses-
sions or study measurements (Table 1). Ideally a
MMSE would be used for this purpose, however due fre-
quently perceived pain at the accident and emergency
A&E department and consequently administered narcotic
analgesics, the hetero anamnestic IQ-CODE is used in-
stead. The coordinating investigator contacts the partici-
pating hospitals on a daily basis by telephone or physically
to ensure adequate and appropriate enrollment of partici-
pants and completeness of data. A list of excluded patients
will be drafted.
Standard care
On arrival at the accident and emergency (A&E) de-
partment patients receive acetaminophen intravenously,
diclofenac (if not contraindicated) and morphine sub-
cutaneously or fentanyl intravenously until numerical
rating scale (NRS)-pain scores have dropped below 4.
Upon admission the local protocol is started (Table 2).
At all centers the 'as needed' medication is administered
when the NRS-pain score is 4 or higher and no excessive
(opioid-induced) sedation is present. Patients who are
deemed able are given intravenous patient controlled anal-
gesia (PCA) pumps with morphine (Table 2). In patients
older than 70 years the bolus setting is reduced by 50 %.
Preferably patients are operated on using spinal
anesthesia. In order to put the patient in an upright pos-
ition for spinal anesthesia administration femoral blocking
with short-acting analgesics can be used. All centers use
bupivacaine 0.5 % between 2.0 and 3.0 ml administered at
the lumbar level. Additional (long acting) analgesics ad-
ministered during surgery are noted. The participating
centers adhere to the Dutch national guidelines for surgi-
cal technique for the various fracture types [43]. Postoper-
atively, on the day of surgery or the first postoperative day
physical therapy is commenced once or twice daily.
Physical therapy sessions are usually 30 min long. In the
period in which the focus of this study lies physical ther-
apy focuses on strengthening of quadriceps and gluteal
musculature, walking and making transfers.
Study apparatus and treatment schedule
Continuous-flow cryocompression therapy is applied by
using the ‘Game Ready system’ (GRS; CoolSystems
Alameda, California). Through an anatomically designed
hip/groin wrap covering most of the thigh and pelvis up
to the iliac crest, the GRS simultaneously delivers both
adjustable continuous-flow cryotherapy and intermittent
compression through a portable control unit filled with
ice and water. The machine has four pressure settings:
no pressure, low pressure (5–15 mm Hg), medium pres-
sure (5–50 mm Hg) and high pressure (5–75 mm Hg).
Temperature can be adjusted between 4 and 13 °C and
is indicated by one, two or three snowflakes. The lowest
temperature is started and maintained throughout the
study if feasible. Pressure is started at ‘low’ and is in-
creased one step per 4 treatments (Table 3). Depending
on the end of surgery patients will be categorized in three
treatment schedules with respective start and end-times
(Table 3). If patients are uncomfortable the appropriate
adjunct will be adjusted stepwise until a comfortable
setting is reached, deviations are noted. Adjustments are
recorded and comfortable settings are maintained accord-
ing to the discomfort flowchart (Fig. 2). Patients will be
treated between 10 and 12 times during the first 72 post-
operative hours, each cycle lasting 30 min. Preferably,
treatment cycles and control measurements during the
first 72 postoperative hours are performed at fixed mo-
ments: 8:00 h, 12:00 h, 16:30 h, and 21:30 h. The GRS-
wrap is only in place when CFC therapy is administered
and applied/removed by the nurse.
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Co-interventions
In case of discomfort the appropriate adjunct is adjusted
accordingly (Fig. 2) and supplemental analgesics are given
as needed (Table 2). In both the intervention group receiv-
ing CFC therapy and in the control group no restrictions
are made towards regularly used static compressive ban-
dages and/or wound drains (with or without autologous
re-infusion). Geriatricians are consulted in a standard
fashion in patients aged 70 years and over.
Admission
Patient demographic data are noted on admission as
well as American Society of Anesthesiologists (ASA)
class, current NRS-pain, delirium observation screen-
ing (DOS)-score, activities of daily living (ADL)-Katz
score and the New Mobility Score (NMS; Table 4) [44–
46]. Time of injury and arrival at the A&E department
is noted. Patient delay intervals longer than 6 h are ac-
tively explored and reasons for delay are clarified e.g. if
Enrollment
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Fig. 1 GRAPES-trial flowchart. * Patient enrollment is allowed up to 6 h postoperative. IMHN: intramedullary hip nail; DHS: dynamic hip screw;
screws: cannulated screws; THA: total hip arthroplasty; HA: hemiarthroplasty; SF-12: Short Form-12; EQ-5D-3L: EuroQol; TUGT: Timed Up and Go
Test; DEMMI: De Morton Mobility Index; SPPB: Short Physical Performance battery
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a patient was prone and unable to call emergency
services.
A standard preoperative venous blood sample is taken in
which hemoglobin, hematocrit and mean corpuscular vol-
umes values are measured (Table 4). Upon admission the
local hospital analgesic and antithrombotic protocol is
started (Table 2). A geriatrician is consulted preoperatively
in patients who are older than 70 years and will focus on:
polypharmacy, risk reduction of falls, prevention and/or
treatment of delirium, optimization of nutritional status.
The ADL-Katz score and delirium risk assessment score
(DRAS) [47] are completed upon admission; furthermore
precipitating factors for delirium (bladder infection and/or
retention, fixation, sleep deprivation, electrolyte abnormal-
ities including renal function impairment) are noted
throughout the hospital stay. After the operation the sur-
geon notes the intraoperative blood loss, the type of implant,
if applicable intraoperative complications, randomizes the
patient and determines the patient’s treatment schedule.
Cryocompression therapy and clinical measurements
Intervention patients start with CFC therapy 6 h postop-
erative, until 72 h postoperatively. A trained ward nurse
will conduct the pain assessments when the patient is in
bed or stationary in a chair for at least five minutes.
Directly before and directly after CFC therapy vital signs
including NRS-pain are measured by the ward nurse,
when the patient is prone in bed for at least five minutes
before commencing and five minutes after cessation of
CFC therapy. In control patients only NRS-pain is mea-
sured at the same time as intervention patients would nor-
mally be assessed. All pain measurements are continued
throughout the first postoperative 72 h for control and
intervention patients alike (Table 4). Three times daily
DOS-scores [48] will be obtained; in case of a DOS-score
higher or equal to three, geriatricians diagnose and
Table 1 Criteria for participants in the trial
Inclusion criteria Exclusion criteria
* Intra or extracapsular
proximal femur fracture
* Fractures at multiple foci
* Open fracture/woundsa
* Aged 18 years and over * Acetabular fracture
* Informed consent or
proxy consent
* (Suspicion of) concomitant malignancy
* BMI > 40
* Unwilling to give proxy consent
* Preoperative osteosynthesis materials in
situ in the ipsilateral leg above knee level
* Morphine allergy or dependence
* ASA ≥ 4
* Cryoglobulinemia
* M. Raynaud
* Central neuromuscular disorder
* Absent ADP/ATP pulsations in the injured
extremity
* Active deep vein thrombosis
* Suspected pulmonary embolism
* Patient delay > 24 h
* NYHA-class ≥ 3
* IQ-CODE score ≥ 4.6*
* Long-acting femoral blocks
* Use of LIA
* Postoperative HD-instability
aOpen wounds unable to close per primam, * The IQ-CODE is only adminis-
tered if the clinician has doubts about the cognitive status of the
intented participant
BMI body mass index, ASA American Society of Anesthesiologists, ADP dorsal
pedal artery, ATP posterior tibial artery, NYHA New York Heart Association,
IQ-CODE Informant Questionnaire for the Cognitive Decline in the Elderly,
LIA local infiltration anesthesia, HD hemodynamic
Table 2 Hospital protocols
Analgesic protocol
Hospital Thrombosis prophylaxis Standard As needed
Spaarne Gasthuis, Hoofddorp Fraxiparine 2850 IU 1xa Acetaminophen
1000 mg 4x
Diclofenac 50 mg 3xb PCA-iv morphine or Morphine 10 mg 6x scc
or Oramorph 10 mg 6xc
If considered able
Noordwest Ziekenhuisgroep Fraxiparine 2850 IU 1xa Acetaminophen
1000 mg 4x
Diclofenac 50 mg 3xb PCA-iv morphine or Morphine 10 mg 6x scc
or Oxycodone 10 mg 6xc
If considered able
VU University medical center Fraxiparine 2850 IU 1xa Acetaminophen
1000 mg 4x
Diclofenac 50 mg 3xb Morphine 10 mg
6x scc
or Oxycodone 10 mg 6xc
Spaarne Gasthuis, Haarlem Fraxiparine 2850 IU 1xa Acetaminophen
1000 mg 4x
Diclofenac 50 mg 3x
or 75 mg iv 2xb
Morphine 10 mg
6x scc
or Oxycodone 10 mg 6xc
Amstelland Hospital Enoxaparine 40 mg 1x Acetaminophen
1000 mg 3x
Diclofenac 75 mg im/iv
2xb
PCA-iv morphine or Piritramide 10 mg 6x scc
or Tramadol 50 mg 3x
If considered able
Reported dosages are dosages given in 24 h
im intramuscular, iv intravenous, sc subcutaneous, PCA patient controlled analgesia
aDosage is doubled in patients weighing > 80 kg
bIf no contraindications exist. c: Dosage is reduced by 50 % in patients aged ≥ 70 years
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subsequently monitor delirium severity with the delirium
rating scale revised 1998 (DRS-R-98) [49] on a daily basis
or until the score drops below 12.25 out of 39 (Table 4).
Time and amount of administered (psychotropic) medica-
tion will be documented. The nurse and ward doctor in-
spect the wound and dressing in accordance with routine
care. Blood samples are taken at postoperative day one
and three, and post-transfusion if applicable (Table 4).
The timed up and go test (TUGT) is performed before
discharge (Table 4). The TUGT will be administered in all
patients who are able. If no weight bearing is allowed or
patients are physically unable, than the test will be post-
poned to the outpatient visit. The mini mental state exam-
ination (MMSE) is administered for data stratification
purposes [50–52], if patients are delirious during admis-
sion the MMSE is postponed to the outpatient visit.
In order to document experiences with CFC therapy all
treatment patients will fill in a questionnaire at discharge,
which is specifically drafted for this study (Table 5). Dur-
ing the study a booklet will be made available into which
staff can write down prevalent occurring technical GRS-
related problems.
Outpatient visit
At the single outpatient study visit between six to eight
weeks, the following parameters are assessed; current
NRS-pain; analgesic use; mobility status by the TUGT,
de Morton Mobility Index (DEMMI) and the Short
Physical Performance Battery (SPPB); current living
situation (rehabilitation or at home); wound status and
complications (thrombosis, consolidation, infection,
readmission). Furthermore the self-assessment health
questionnaires EuroQol(EQ)-5D-3 L and Short Form
(SF)-12 are completed. If not administered during ad-
mission the MMSE is completed (Table 4).
Data collection and handling
Upon inclusion patient characteristics are entered in RM
and postoperative randomization takes place. A unique
patient number is generated by RM, which will be used
for further data collection on preformatted case report
forms (CRF’s). Only the coordinating investigator has ac-
cess to the key-file that can identify patients from RM-
generated patient numbers, it will be stored at the co-
ordinating center throughout and after completion of the
trial and will not be shared. The Spaarne Gasthuis is the
unrestricted owner of the final dataset; no contractual
agreements exist in regard to publication policies. No in-
terim analysis will be performed.
Data management team
The coordinating center comprises of: the principal investi-
gator, the coordinating investigator, a research nurse, a re-
search assistant, a clinical epidemiologist and statistician.
The research assistant enters data in RM. The research
nurse can be contacted via telephone to solve any (acute)
problems that might occur and enters data in RM. The epi-
demiologist and statistician assist with data analyses and
drafting of the manuscript. During the enrollment phase of
the trial the coordinating investigator meets bimonthly with
the individual principal investigators of the respective cen-
ters to assess the current inclusion rate, data quality,
Table 3 Treatment schedule and pressure settings
End time surgery Schedule Start time
10:00 – 16:00 h A 16:30 h
16:00 – 21:00 h B 21:30 h
>21:00 h C 8:00 h
Cycle no.→ 1 2 3 4 5 6 7 8 9 10 11 12
OK + 0 A: – Low A – Low
B: – Low -
- -
OK + 1 - - A – Low A – Low A – Med A – Med
- B – Low B – Low B – Low B – Med -
C – Low C – Low C – Low C – Low - -
OK + 2 - - A – Med A – Med A – High A – High
- B – Med B – Med B – Med B – High -
C – Med C – Med C – Med C – Med - -
OK + 3 - - A – High A – High
- B – High B – High B – High
C – High C – High C – High C – High
Regular treatment times: 8:00 h; 12:00 h; 16:30 h; 21:30 h
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protocol adherence and prevalent occurring problems.
During enrollment two meetings are planned to collect-
ively assess problems and deliberate on how to instigate
solutions to these problems. All participating personnel
are updated on a monthly basis via a newsletter in which
current inclusion rates are presented, and to point out
points of attention and solutions to frequently observed
problems. During physical visits CRF’s are collected,
assessed for completeness and missing data is retrieved
from patient medical records where possible; secondly the
appropriateness of administered treatments and (func-
tional) tests is assessed.
Data monitoring committee
Two independent data monitors are instigated and will
monitor the trial at two of the five sites where highest
inclusion rates are expected. Results of the monitor will
be discussed in a committee independently of the inves-
tigators and the investigators will be informed both
orally and in writing. Since the overall risk of participa-
tion in the trial is considered low by the REC/IRB no ex-
ternal safety overseers are required by national
guidelines. If selected, external auditing is possible.
Outcome parameters
NRS-pain (primary)
The verbally administered 11-point (range 0–10) NRS-
pain is a widely accepted assessment tool and has been val-
idated in many different conditions, among is acute pain in
the emergency department [53–55]. Reliability and validity
has been thoroughly studied in (cognitively impaired) eld-
erly and has shown to maintain acceptable clinometric
characteristics [56–58]. NRS-pain scores are compared
within the intervention group i.e. pre and post-treatment
and compared between the intervention and control
groups. Cumulated pain scores will be calculated for both
groups by adding the (post-treatment) pain scores of the














Fig. 2 Discomfort flowchart. * If a patient reports discomfort for the second time at the same setting this setting is permanently reduced to the
setting deemed comfortable
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Analgesic use
All postoperative oral and parenteral administered nar-
cotic analgesics will be converted and added up using
accepted algorithms [59, 60] and compared after the
last treatment day, at discharge and at the outpatient
clinic. Total milligrams of acetaminophen and non-
steroidal anti-inflammatory drugs (NSAID’s) are re-
ported in the same fashion. At the outpatient visit
patients will be asked about their current pain medica-
tion use.
Postoperative blood loss and transfusion incidence
The hemoglobin values from the obtained blood samples
at postoperative day one and three will separately be
detracted from the preoperative concentration and post-
operative day three will be detracted from postoperative
day one. An adjustment will be made for the intraopera-
tive blood loss. Indications for transfusion are managed
according to the Dutch national blood transfusion guide-
line [61]. Normovolemic ASA-one patients older than
60 years who lose blood at a single locus will be











NMS, KATZ-ADL X X
Delirium risk assessment DRAS X
Cognitive function IQ-CODE X
MMSE X X
Blood loss Intraoperative loss (cc’s) X
Drain outputa(cc’s) X X X X
Outcome
Pain NRS X X X X X X X
Analgesics Acetaminophen X X X
NSAID’s X X X
Morphine X X X
Blood loss Hemoglobin (mmol/l) X X X
Transfusion incidence Number of units X X
Delirium DOS-score X X X X X X
DRS-R-98c X X X X X
Pyschotropic medication X X X
Length of stayb (Hours) X
Functional outcome TUGT X X
DEMMI X
SPPB X
Rehabilitation location X X




Complications General X X
Therapy related X X
Feasibility Nurse staff questionnaire At discharge
of last patient
A&E accident and emergency, NMS New Mobility Score, IQCODE-N Informant Questionnaire on the Cognitive Decline in Elderly patients, MMSE Mini Mental
State Exam, NRS numeric rating scale, PC packed cells, DOS Delirium Observation Screening, DRS-R-98 Delirium Rating Scale Revised 98, TUGT Timed Up and
Go Test, DEMMI De Morton Mobility Index, EQ-5D-3L EuroQol questionnaire, SF-12 Short Form-12 questionnaire
aIncluding autologous reinfusion. bStart count at admission and at the end of surgery. c: administered when DOS ≥ 3
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transfused at 5 mmol/l (8 g/dl). Patients unable to ele-
vate cardiac output for hemodilution are transfused at
6 mmol/l (9.6 g/dl). Incidence of erythrocyte transfusion
is noted and compared between groups.
Postoperative delirium
The DRS-R-98 is considered to be a valid and reliable
instrument for delirium diagnosis and documenting delir-
ium severity [49, 62]. It takes a trained nurse or physician
five to ten minutes to assess the patient and comprise the
DRS-R-98 score, and is ideal for longitudinal delirium
follow-up. The sensitivity and specificity of the scale are
reported to be 92 % and 86 % respectively. DRS-R-98
scores are compared within and between groups, and
newly started psychotropic medication is compared.
Length of stay
Admission time is measured and expressed in two ways:
from arrival time at the A&E department until discharge and
from end of surgery to until discharge. The discharge criteria
in all participating centers are: NRS-pain score below 5 with-
out need for parenteral analgesics and an Elderly Mobility
Scale (EMS) score 14 out of 20 or higher [63, 64]. If this
some items were deemed unobtainable EMS scores are com-
pleted until transfer to a nursing home is arranged. If family
members are able to foresee in certain home care aspects the
patient can be discharged to his/her home. The fulfillment of
this care by family is noted and corrected for afterwards.
Functional outcome
Timed Up and Go Test
The TUGT is a functional mobility test that measures
the time it takes a patient to get up out of a chair, walk
3 m and return in a sitting position. The test is easy to
use and has sufficient clinometric characteristics [65],
can predict short-term risk of new falls [66] and func-
tional outcome over time [67]. Detailed instructions are
provided to the patient: rise from the chair (knees at 90°
flexion) when you hear “go”, walk at safe speed to the
mark on the floor and back, the time stops when you hit
the chair with your buttocks. The physical therapist will
demonstrate how to perform the TUGT once. The aver-
age of three tests will be the final TUGT outcome and
no trial run is performed. Postoperative mobilization
policy is noted and patients are stratified in three
groups: no weight bearing, partial weight bearing or full
weight bearing. Preferably no walking aid will be used
during the test but if needed, the patient can use any
walking aid available, the type of aid used will be re-
corded. The updated NMS is administered at inclusion
for data stratification purposes [44, 45, 68]. NMS will be
classified as low when NMS is 2-6 and scored high when
NMS is 7–9 [46].
De Morton Mobility Index
The DEMMI is a measure of mobility that has been val-
idated in hip fracture patients [69-71]. The DEMMI is
administered by physician or physical therapist obser-
vation of the test subject’ physical performance, mea-
sured in 15 hierarchical domains (three bed, three
chair, four static balance, two walking and three dy-
namic balance items), each measured on a two (able/
unable) or three (able/partial/unable) point scale. It
takes a trained person ten minutes to administer the
test in elderly patients. The raw score is converted to
an interval score.
Table 5 Patient questionnaire
1. Did you feel that the pain reduced when treated with cryocompression therapy? A B C D E
2. Would you rather have cryocompression treatment than analgesic pain treatment? A B C D E
3. The standard setting used was the coldest; did you like this temperature setting? A B C D E
4. Did you request the temperature setting to be upped? Y N
5. Did you like the dynamic pressure adjunct? A B C D E
6. The pressure adjunct was elevated every 4 treatments, was the pace to fast? A B C D E
7. After treatment the muscles are cooled, did this hinder you in moving around outside of bed? A B C D E
8. Would you have liked to be treated more often per day than 4 times? A B C D E
9. Would you have liked to be treated longer than 30 min per cycle? A B C D E
10. Would you have liked to be treated longer than the first 72 h postoperative? A B C D E
11. Did you feel like you recovered faster with cryocompression therapy? A B C D E
12. Would you recommend the use of cryocompression therapy to other patients? A B C D E
13. Can you briefly describe what you think are advantages of cryocompression therapy? Open text
14. Can you briefly describe what you think are disadvantages of cryocompression therapy? Open text
15. From 0 – 10 how would you rate the cryocompression treatments in general? (0-10)
A: agree completely; B: agree; C: neutral; D: disagree; E: disagree completely
Y: yes; N: no
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Short Physical Performance Battery
The SPPB is composed of three tasks: a hierarchical
balance task, a short walk at normal speed, and five
repetitive chair stands. Low scores in the SPPB have
predictive value for a wide range of health outcomes:
mobility loss, disability, hospitalization, length of hos-
pital stay, nursing home admission, and death [72-75].
Normative values of SPPB have been published for
representative populations by five-year age groups and
sex [73]. The strong and consistent association with
health status measures demonstrated the validity of
the SPPB [76].
Patient reported outcome measures
EQ-5D-3L
The EuroQol/EQ-5D-3L is a validated, generalized and
standardized instrument comprising a VAS measuring
self-rated health and a health status instrument, consisting
of a three-level response (no problems, some problems
and extreme problems) for five domains related to daily
activities; (i) mobility, (ii) self- care, (iii) usual activities,
(iv) pain and discomfort and (v) anxiety and depression.
Responses to the health status classification system are
converted into an overall score using a published utility
algorithm for the Dutch population [77]. A respondent’s
EQ-VAS gives self-rated health on a scale where the end-
points are labeled ‘best imaginable health state’ (100) and
‘worst imaginable health state’ (0).
Short Form-12
The SF-12 is the abbreviated version of the original SF-
36 and scores quality of life in two domains, physical
and mental health. It has shown good correlation with
the SF-36 and proved valid in many conditions, amongst
is orthopedic surgery [78].
Complications
The surgeon monitors all complications that may occur
throughout admission, in general or cryotherapy-related.
After discharge the coordinating investigator verifies if
all adverse events are registered and recorded on the
appropriate CRF. In case of serious adverse events relat-
ing to the treatment patients will no longer receive treat-
ment but will remain in the study for follow-up, if
feasible. Severe leakage i.e. multiple bandage swaps daily
is noted and registered as an adverse event. Furthermore
an intragroup analysis of vital signs is made to deter-
mine possible central effects of the administered therapy.
Finally, at the outpatient visit patients are assessed for
adverse events that may have occurred during rehabilita-
tion. Additional to the patient questionnaire (Table 5),
intervention patients are asked about their experiences
with CFC therapy. An additional insurance is taken out
to financially compensate participants if applicable. Ad-
verse events are tabulated and reported in the final
manuscript.
Feasibility
At the end of the study nursing staff will complete ques-
tionnaires specifically drafted for this study (Table 6)
and the booklet of prevalent technical problems will be
evaluated. A close out visit will be planned in which rec-
ommendations for further improvement of the machine
will be discussed. Treatment failure i.e. discontinuation
of treatment is reported and provided with reasons e.g.
discomfort.
Statistics
Analysis of outcome parameters
All statistical analyses will be computed using the SPSS
statistical package (IMB SPSS, Inc., Release 20.0.0.0, 64-bit
edition). Statistical analysis will be performed according to
Table 6 Nursing staff questionnaire
1. Was the GRS hip/groin wrap technically easy to apply? A B C D E
2. Was the GRS hip/groin wrap easy to apply to postoperative hip fracture patients? A B C D E
3. Did you apply the GRS hip/groin wrap alone? Y N
4. Was the control unit easy to operate? A B C D E
5. If the GRS works do you think that the application (4 times 30 min a day) is feasible in daily practice? A B C D E
6. Were you able to administer all the treatments that were required? A B C D E
7. Would you recommend cryocompression therapy to patients? A B C D E
8. Do you think patients recovered faster because of cryocompression therapy? A B C D E
9. Should the cryocompression therapy be apart of standard hip fracture treatment? A B C D E
10. Can you briefly describe what you think are advantages of cryocompression therapy? Open text
11. Can you briefly describe what you think are disadvantages of cryocompression therapy? Open text
GRS Game Ready system
A: agree completely; B: agree; C: neutral; D: disagree; E: disagree completely
Y: yes; N: no
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the intention-to-treat principle. Baseline characteristics
will be described in accordance with CONSORT guide-
lines [41] using means and standard deviation in case of
normal distribution, and medians and interquartile ranges
otherwise. Continuous variables will be checked for nor-
mality, visually and by using the Shapiro Wilk test. Our
primary analysis focuses on the differences in NRS-pain
scores between the study groups 24 h postoperative and
will be analyzed by use of Student’s T or Mann–Whitney
U tests in case of skewed distribution. To assess treatment
effect over time, a mixed model analysis for repeated mea-
sures will be performed. This model allows missing data
and adjustment for serious confounders and interactions.
In case of skewed distributions and outliers non-
parametric variants will be used (e.g. Mann Whitney U or
Friedman tests). Secondary continuous outcome measures
(EQ-5D-3L, SF-12, DRS-R-98 and hemoglobin) will be
compared by use of Student’s t or Mann Whitney U tests.
Ordinal variables will be analyzed using the Mann–Whit-
ney test. Chi-squared tests will be performed in case of
categorical variables. In case of important confounding,
analysis will be adjusted to correct for these factors (by
use of multiple regression analysis, linear or logistic). A p-
value of < 0.05 will be considered statistically significant.
Sample size calculation
Sample size calculation is based on the primary outcome
measure, NRS-pain at 24 h postoperatively. Subsequently,
a mean NRS-pain score for postoperative day one was
drawn from the Spaarne Gasthuis electronic patient
dossier digital databanks and a standard deviation of 2.2
was calculated for pooled internal fixation and (hemi)
arthroplasty for cervical and peritrochanteric fractures.
The minimal clinical relevant difference for NRS-pain is
1.3 out of 10 [53]. The alpha was set at 5 % with a power
of 90 % due to anticipated heterogeneity in regard to
operating techniques, general care protocols but pre-
dominantly in regard to pain protocols between the
participating centers (Table 2). An expected NRS failure
rate of 10 % is anticipated together with expected miss-
ing data a drop out of 22.3 % is computed. The total
number of included patients will be 160.
Dissemination policy
The trial outcome will be published as an international
peer-reviewed article. Any modifications to the protocol
which may impact on the conduct of the study, potential
benefit of the patient or may affect patient safety, including
changes of study objectives, study design, patient popula-
tion, sample sizes, study procedures, or significant adminis-
trative aspects will require a formal amendment to the
protocol. Such amendment will be agreed upon by the
REC/IRB and will be reported to www.trialregister.nl and
to this journal.
Discussion
This multicenter study will evaluate the efficacy of inter-
mittent application of continuous-flow cryocompression
therapy administered in the first 72 postoperative hours
after hip fracture surgery. Due to the multicenter design
of the study the results can easily be translated to the
general care of hip fracture patients. Conversely, some
inequality in local hospital pain protocols is present but
conversion through accepted algorithms [59, 60] make
comparison feasible. Spinal anesthetized patients could
have advantages over the general anesthesia group in the
acute hours post-surgery in regard to pain scores and
analgesic use since the effect of the latter ends immedi-
ately after surgery in contrast to the former that takes a
few hours to wear off completely.
The varying types of fractures have different characteris-
tics and demand a different surgical approach. Peritrochan-
teric fractures quite often have more extensive bony trauma
and less soft-tissue trauma, and after surgical stabilization
with a DHS or IMHN fracture micro-motion leads to pro-
longed and greater dynamic pain [6]. Conversely, in (hemi)
arthroplasty the fracture-site is removed completely at the
expense of increased (surgical-induced) soft-tissue trauma.
Hence the efficacy of CFC therapy is likely to vary in pa-
tients with varying extent of soft-tissue trauma. Therefore
stratification is implemented according to type of surgery
that divides patients with greater surgical trauma ((hemi)
arthroplasty) and lesser surgical trauma (cannulated screws,
DHS, IMHN).
By nature, delirium is known to fluctuate over the day
and a single DRS-R-98 measurement might not reach
sufficient sensitivity for diagnosis. However with longitu-
dinal follow-up of three times daily DOS-scores this prob-
lem is overcome for the most part. Delirium severity is
assessed with more information gathered from family and
personnel, over the past 24 h thereby making assessment
adequate.
Currently three of the four participating hospitals have
a geriatric trauma unit, in one of the hospitals with a
geriatric trauma unit the care of the surgical geriatric pa-
tient is transmitted to the geriatrician in full except for
wound assessments and related care. At this ward all pa-
tients receive prophylactic haloperidol 1 mg daily, and
more if needed. At the hospital without a geriatric
trauma unit a geriatrician is not readily available and un-
able to attend the clinic on a daily basis. Confounding of
secondary outcomes as delirium, psychotropic medication
and functional outcome can therefore not be ruled out.
When compared to the preoperative values, hemoglobin
levels in collected blood samples at postoperative day one
are usually much lower than one would expect from the
observed blood loss during surgery. This gap called ‘the
hidden blood loss’ is thought to arise from, among others
gastro-intestinal bleeding [22, 79]. The amount of
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(hidden) blood loss is more severe when oral anticoagu-
lants or thrombocyte aggregation inhibitors compromise a
patient’s hemostasis and this loss may continue through-
out the early postoperative period. Hemoglobin measured
at postoperative day one is most likely, as opposed to the
preoperative values, significantly diluted, thereby underesti-
mating the actual hemoglobin concentration. Combined
with the possibility of hidden blood loss throughout the
hospital stay, care has to be taken when comparing the
value of postoperative day one to day three.
The functional outcome assessment of patients who
are not allowed to bear weight at the time of discharge
is postponed to the outpatient clinic. At this visit they
are allowed to bear weight for the first time in weeks.
Testing directly after weight bearing for the first time
can introduce confounding.
Finally, care has to be taken to interpret the allocation
to rehabilitation facilities. For instance patients who have
sufficient family members who can help out at home are
more likely to be discharged home with or without
homecare rather than be assigned to a rehabilitation
clinic or nursing home with rehabilitation facilities.
Conclusion
The present study will provide evidence for the efficacy
of continuous-flow cryocompression therapy applied
after hip fracture surgery. Due to the duplicate trauma
this condition encompasses these patients, who are gener-
ally aged 70 years and over, are expected to benefit most.
Furthermore treatment feasibility is assessed and conse-
quently, recommendations are made about which settings
are best to employ.
Ethics and consent to participate
Permission has been obtained from the 'Medisch
Ethische Toetsingscommissie Noord-Holland' regional
medical ethics committee (NL45657.094.14) and the trial
is registered at www.trialregister.nl on the 23rd of
August 2013 with trial number: “NTR4152”. Patients
with an intra or extracapsular hip fracture who meet the
inclusion criteria and without apparent exclusion criteria
(Table 1) are informed about the study both orally and
in writing by the assessing physician e.g. the local ward
doctor, staff member or consulting geriatricians. Depend-
ing on operating room capacity and patient characteristics
patients will either first be transferred to the ward or will
go directly to the operating room. Patients can be in-
cluded pre and postoperatively within 6 h post surgery,
before the first treatment starts 6 h postoperative (Fig. 1).
Maximum time for consideration to participate in the
study is set at 12 h. Patients approving to participate need
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